Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01RVA
|
||||
Former ID |
DIB017030
|
||||
Drug Name |
ADR-851
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Vomiting and nausea [ICD9: 787, 787.0; ICD10:R11] | Phase 1 | [1] | ||
Company |
Adria Laboratories Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H19Cl2N3O2
|
||||
Canonical SMILES |
c1(c2c(c(c(c1)Cl)N)CCO2)C(=O)NC[C@H]1NCCC1.Cl
|
||||
CAS Number |
CAS 123805-17-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001323) | ||||
REF 2 | Analgesic effects of S and R isomers of the novel 5-HT3 receptor antagonists ADR-851 and ADR-882 in rats. Eur J Pharmacol. 1991 Oct 29;204(1):117-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.